We examined the baseline features and clinical outcomes of 140 patients presenting with JAK2V617F positivity and a bone marrow morphology conforming with WHO criteria of polycythemia vera (PV), but a hemoglobin level of <18.5 g/dL in males (range 16.0-18.4) and <16.5 g/dL in females (range 15.0-16.4). This cohort operationally referred to as masked PV (mPV) was compared with 257 patients with overt PV and displayed male predominance, a more frequent history of arterial thrombosis and thrombocytosis. Incidence of thrombosis was similar between the two groups but mPV displayed significantly higher rates of progression to myelofibrosis and acute leukemia and inferior survival. In multivariable analysis mPV diagnosis was an independent predictor of poor survival along with age >65 years and leukocyte count >10 x 10(9) /L. Our data suggest that mPV is a heterogeneous myeloproliferative neoplasia and not necessarily an early/ pre-polycythemic form of classical PV that at onset in a small fraction of patients clinically may mimic essential thrombocythemia. On the other hand, the majority mPV may have a longer prodrome of undiagnosed PV or a disease biology akin to primary myelofibrosis-post PV myelofibrosis that could explain the worsening of outcome in comparison to overt/classical manifestations.

Masked polycythemia vera (mPV): results of an international study / Barbui, T; Thiele, J; Gisslinger, H; Finazzi, G; Carobbio, A; Rumi, E; Randi, Ml; Bertozzi, I; Vannucchi, Am; Pieri, L; Carrai, V; Gisslinger, B; Mullauer, L; Ruggeri, M; Rambaldi, A; Tefferi, A. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 1096-8652. - 89:12(2014), pp. 52-54. [10.1002/ajh.23585]

Masked polycythemia vera (mPV): results of an international study

Carobbio A;
2014

Abstract

We examined the baseline features and clinical outcomes of 140 patients presenting with JAK2V617F positivity and a bone marrow morphology conforming with WHO criteria of polycythemia vera (PV), but a hemoglobin level of <18.5 g/dL in males (range 16.0-18.4) and <16.5 g/dL in females (range 15.0-16.4). This cohort operationally referred to as masked PV (mPV) was compared with 257 patients with overt PV and displayed male predominance, a more frequent history of arterial thrombosis and thrombocytosis. Incidence of thrombosis was similar between the two groups but mPV displayed significantly higher rates of progression to myelofibrosis and acute leukemia and inferior survival. In multivariable analysis mPV diagnosis was an independent predictor of poor survival along with age >65 years and leukocyte count >10 x 10(9) /L. Our data suggest that mPV is a heterogeneous myeloproliferative neoplasia and not necessarily an early/ pre-polycythemic form of classical PV that at onset in a small fraction of patients clinically may mimic essential thrombocythemia. On the other hand, the majority mPV may have a longer prodrome of undiagnosed PV or a disease biology akin to primary myelofibrosis-post PV myelofibrosis that could explain the worsening of outcome in comparison to overt/classical manifestations.
2014
89
12
52
54
Masked polycythemia vera (mPV): results of an international study / Barbui, T; Thiele, J; Gisslinger, H; Finazzi, G; Carobbio, A; Rumi, E; Randi, Ml; Bertozzi, I; Vannucchi, Am; Pieri, L; Carrai, V; Gisslinger, B; Mullauer, L; Ruggeri, M; Rambaldi, A; Tefferi, A. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 1096-8652. - 89:12(2014), pp. 52-54. [10.1002/ajh.23585]
Barbui, T; Thiele, J; Gisslinger, H; Finazzi, G; Carobbio, A; Rumi, E; Randi, Ml; Bertozzi, I; Vannucchi, Am; Pieri, L; Carrai, V; Gisslinger, B; Mullauer, L; Ruggeri, M; Rambaldi, A; Tefferi, A
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1331670
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 107
social impact